To further refine the predictive accuracy of the Ascore signature, we expanded our analysis to include PD-L1 expression in tumor-infiltrating immune cells (ICs) as shown in Fig. S10B. These ICs—comprising macrophages, dendritic cells, and lymphocytes—are considered instrumental in shaping immunotherapy response in bladder cancer. This evidence concerns the gene CD274 and neoplasm.